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AbstrAct
Background & Aims: All-trans Retinoic acid (RA) regulates hepatic lipid and bile 
acid homeostasis. Similar to bile acid (BA), RA accelerates partial hepatectomy (PHx)-
induced liver regeneration. Because there is a bidirectional regulatory relationship 
between gut microbiota and BA synthesis, we examined the effect of RA in altering 
the gut microbial population and BA composition and established their relationship 
with hepatic biological processes during the active phases of liver regeneration.
Methods: C57BL/6 mice were treated with RA orally followed by 2/3 PHx. The 
roles of RA in shifting gut microbiota and BA profiles as well as hepatocyte metabolism 
and proliferation were studied. 
Results: RA-primed mice exhibited accelerated hepatocyte proliferation revealed 
by higher numbers of Ki67-positive cells compared to untreated mice. Firmicutes and 
Bacteroidetes phyla dominated the gut microbial community (>85%) in both control 
and RA-primed mice after PHx. RA reduced the ratio of Firmicutes to Bacteroidetes, 
which was associated with a lean phenotype. Consistently, RA-primed mice lacked 
transient lipid accumulation normally found in regenerating livers. In addition, RA 
altered BA homeostasis and shifted BA profiles by increasing the ratio of hydrophilic 
to hydrophobic BAs in regenerating livers. Accordingly, metabolic regulators fibroblast 
growth factor 21, Sirtuin1, and their downstream targets AMPK and ERK1/2 were 
more robustly activated in RA-primed than unprimed regenerating livers.
Conclusions: Priming mice with RA resulted in a lean microbiota composition 
and hydrophilic BA profiles, which were associated with facilitated metabolism and 
enhanced cell proliferation.
INtrODUctION
The gut microbiota plays a crucial role in promoting 
cell proliferation. For examples, germ-free mice have 
reduced intestinal epithelial cell turnover due to decreased 
proliferation, apoptosis, and crypt-to-tip cellular migration 
[1]. Gut microbiota-generated toll-like receptor signals 
are required for injured tissues to regenerate and regain 
homeostasis [2]. Moreover, conventional mice have 
reduced cancer incidence compared with germ-free mice 
[3], and an increased bacterial load is found in colonic 
biopsies from patients with colorectal adenoma or cancer 
[4]. One mechanism by which bacteria promote cell 
proliferation is through the stimulatory effect of gram 
negative bacteria-generated lipopolysaccharide (LPS) 
on DNA synthesis [5]. It has been shown in mice that 
hepatic DNA synthesis is impaired when gut-derived LPS 
is blocked from reaching the liver [6]. Furthermore, both 
germ-free and LPS-resistant mice exhibit delayed liver 
regeneration after liver resection, which can be rescued 
by LPS administration [7]. In addition to proliferation, 
the gut microbiota modulates host metabolic phenotype 
and participates in microbial-host co-metabolism [8]. 
Alterations in gut bacterial communities are associated 
with metabolic disorders [9], metabolic syndrome [10], 
obesity [11-13], and nonalcoholic steatohepatitis [14]. 
Taken together, there is a close relationship between 
microbial-host metabolism and tissue injury as well as 
regeneration [15, 16]. 
Besides LPS, another gut-derived signaling that 
contributes to liver regeneration is bile acid (BA). 
There is substantial metabolic demand during liver 
regeneration, and proper function of intestinal nutrient 
absorption-mediated by BAs is essential for normal liver 
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repair. The hydrophobic nature of BAs facilitates lipid 
absorption while conjugated hydrophilic BAs are more 
effective in lipid emulsification [17]. Fine-tuned lipid 
and BA homeostasis is important in supporting liver 
regeneration. Steatosis dampens liver repair capability 
[18, 19], and leptin-inhibited hepatic fat accumulation 
also impairs partial hepatectomy (PHx)-induced liver 
regeneration [20]. Additionally, BA overload induces 
liver injury in regenerating liver and increases mortality 
[21-23]. However, BA depletion by cholestyramine 
reduces liver regeneration capability, and the restored 
liver mass is reduced by 50% [24]. Together, maintaining 
BA homeostasis is crucial for normal progression of liver 
regeneration [15, 16]. 
Hepatic enzymes together with bacteria enzymes 
are responsible for generating various kinds of BAs. 
Microbiota plays a pivotal role in BA synthesis by 
increasing BA composition diversity via de-conjugation, 
dehydrogenation, dihydroxylation, and sulfation of 
primary BAs in the gastrointestinal (GI) tract [25]. 
Bile salt hydrolase (BSH) detected from Bacteroides, 
Bifidobacterium, and Lactobacillus catalyzes the de-
conjugation of BAs to liberate free primary BAs. 
Furthermore, several bacteria belonging to the 
Firmicutes phylum have hydroxysteroid dehydrogenase, 
which mediates BA oxidation and epimerization. The 
compositions of BAs between germ-free and conventional 
rats are markedly different [26]. A cross-sectional study of 
patients with cirrhosis showed elevated primary BAs and 
Enterobacteriaceae and diminished 7α-dehydroxylating 
bacteria including Lachonospiraceae, Ruminococcaceae, 
and Blautia, which convert free BAs to secondary BAs 
[27]. Gut microbiota-generated deoxycholic acid (DCA) 
and lithocholic acid (LCA) induce cell proliferation and 
GI cancers [28]. These findings clearly indicate that gut 
microbiota modulate host BA synthesis and diversity, 
which in turn influence liver function. 
Similar to BAs, all-trans retinoic acid (RA), 
naturally presented in the GI tract, has a profound 
effect in regulating lipid homeostasis [29, 30]. We have 
previously shown that RA can facilitate PHx-induced 
liver regeneration via inducing cell cycle gene expression, 
which was comparable to the liver regeneration effect 
of cholic acid (CA) [24, 31]. Because of the intimate 
relationship between gut-derived signaling and liver 
regeneration, we hypothesize that RA may regulate gut 
microbiota and BA composition thereby promoting 
hepatocyte proliferation in regenerating livers. To test 
this hypothesis, we analyzed the gut microbiota and BA 
composition to understand their potential role in PHx-
induced liver regeneration in response to RA treatment. 
Our data showed that priming mice with RA resulted in a 
lean microbiota composition and hydrophilic BA profile, 
which were associated with facilitated metabolism and 
accelerated hepatocyte proliferation.
rEsULts
Priming mice with rA accelerated liver 
regeneration
Wild type mice received an oral gavage of RA or 
vehicle, and PHx was performed 48 hours later. RA-
primed mouse livers had higher induction of cell cycle 
gene expressions, including Cyclin D (0-1, 2 day), Cyclin 
E (0-2 day), Cyclin A (0-1.5 day), and Cyclin B (0-2 
day) (Figure 1A). The hepatic protein levels of CYCLIN 
D (0-0.5 day) and CYCLIN A (0-1 day) also showed 
increased induction (Figure 1B). RA-induced cell cycle 
gene expression correlated with enhanced liver regrowth 
and proliferation, as shown by greater liver-to-body 
weight ratio and numbers of Ki67-positive cells at all 
studied times (Figure 1C). Together, RA administration 
accelerated liver regeneration. Interesting, lipid droplets, 
usually occurring 1-1.5 day after PHx [18], were absent 
in RA-primed mouse livers (Figure 1D), indicating a 
regulatory effect on lipid metabolism by RA during liver 
regeneration. 
Priming mice with rA altered gut microbiota 
during liver regeneration
Firmicutes and Bacteroidetes phyla dominated 
the microbial community ( > 85%) in both control and 
RA-primed mice during liver regeneration (Figure 2A). 
In control mice, there was a transient increase in the 
abundance of Verrucomicrobia which rose to 7% on day 
1, continued increasing to 15% on day 1.5, and contracted 
to 0.6% on day 2. However, in RA-primed mice, the 
Verrucomicrobia increase was only detected on 1.5 day 
after PHx (Figure 2A). RA-treated mice had a reduced 
ratio of Firmicutes to Bacteroidetes 1 day after surgery 
(2-fold increase in Bacteroidetes) (Figure 2B). The 
Ruminococcaceae and Lachnospiraceae are two of the 
most abundant families from the Firmicutes phyla found in 
the mammalian intestine, and are associated with intestinal 
health [32]. Higher levels of Ruminococcaceae (day 
2) and Lachnospiraceae (0, 0.5, 2 days) were observed 
in RA-primed mice (Figure 2C). At the genus level, 
Akkermansia from the Verrucomicrobia phyla appeared on 
day 1 (7%), increased to 14.6% on day 1.5, and became 
undetectable on day 2 in the control mice. The appearance 
of Akkermansia was delayed in RA-treated mice (Figure 
2D). RA increased the abundance of genus Lactobacillus 
by four folds on day zero (Figure 2D). The abundance 
of Bifidobacterium was also dramatically higher in RA-
primed mice on day zero and 1 day after PHx ( > 9 folds) 
(Figure 2D). 
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Figure 1: Accelerated liver regeneration in rA-primed mice. Wild type (WT) mice were treated with all-trans retinoic acid (RA) 
or vehicle by oral gavage 48 hours prior to partial hepatectomy (n = 4). A. Quantitative RT-PCR analyses of hepatic mRNA level of Cyclin 
D, Cyclin E, Cyclin A, Cyclin B. b. Immunoblotting of liver extracts using anti-CYCLIN D and CYCLIN A antibodies. c. Liver-to-body 
weight ratios and immunohistochemistry of liver sections for Ki67 staining (20×) are shown. The number of Ki67-labeled nuclei was 
counted in at least 10 low-magnification (20×) microscope fields for each liver section. D. H&E staining of liver sections. Representative 
images are shown (20×). Means ± SD are graphed with * indicating p < 0.05.
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rA regulates the expression of bA homeostasis 
genes during liver generation
Studies of the hepatic BA synthesis pathway 
revealed that priming mice with RA reduced the expression 
of hepatic cholesterol 7α-hydroxylase (Cyp7a1) and sterol 
12α-hydroxylase (Cyp8b1) on day zero. At the protein 
level, RA reduced CYP7A1 (0-1 day) and CYP8B1 (0, 
1, 2 day), but increased CYP8B1 on day 1.5 (Figure 3A). 
In the ileum, PHx itself induced small heterodimer 
partner (Shp) and fibroblast growth factor (Fgf15) 
expression immediately after surgery (day 0.5) and this 
induction was sustained throughout the active phase of 
hepatocyte proliferation. Priming mice with RA further 
increased the expression of Shp (0.5 day) and Fgf15 
(0-0.5 day) indicating an effect of RA in modulating 
BA-mediated FXR signaling in the ileum during liver 
regeneration (Figure 3B). SHP and FGF15 protein levels 
showed a consistent increase with the biggest difference on 
0.5 day (Figure 3B). Similar patterns were also observed 
for the expression of ileal organic anion transporting 
polypeptide-2 (Oatp2), apical sodium-dependent bile 
acid transporter (Asbt), and ileal bile acid-binding protein 
(Ibabp). The expression of these transporters was induced 
after PHx, indicating increased intestinal BA uptake 
during liver regeneration [33]. Furthermore, RA enhanced 
the expression of Oatp2 (0-0.5 day), Asbt (0.5, 2 day), and 
Ibabp (0-1 day) (Figure 3C). Organic solute transporter 
beta (Ostβ), a basolateral BA efflux transporter, was also 
induced in the ileum during liver regeneration, and its 
induction was further enhanced by RA-priming (day 0.5) 
(Figure 3C). RA had no effect in regulating ATP-binding 
cassette, sub-family g, member 5 (Abcg5), Abcg8, Ostα, 
and Abca1 expression. However, these genes were induced 
in regenerating livers (Figure 3D). 
RA alters hepatic BA profile during liver 
regeneration
Hepatic BAs quantification showed that priming 
mice with RA had no effect on the amount of total bile 
acids (TBA) (Figure 4A). However, RA treatment 
shifted the composition of free BAs (Figure 4B). 
Tauro-conjugation of BAs increases their hydrophilic/
hydrophobic ratio, solubility and lipid emulsification 
[17], and the taurocholic acid (TCA)/CA ratio was 
significantly higher in RA-treated mice compared to 
controls (Figure 4C). The tauro-β-muricholic acid (T-β-
MCA) to β-muricholic acid (β-MCA) ratio, associated 
with increasing lipid emulsion efficiency [8, 17], was also 
higher in RA-primed mice compared to controls on day 
zero and 1 day after PHx (Figure 4D). 
Figure 2: the effect of rA on gut microbiota during liver regeneration. RA-primed mice showed altered gut microbiota 
composition A., the ratio of Firmicutes to Bacteroidetes b., family levels of Ruminococcaceae and Lachnospiraceae c., and genus levels 
of Akkemansia, Lactobacillus, and Bifidobacterium D.. Means ± SD are graphed with * indicating p < 0.05.
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Figure 3: the effect of rA on the expression of genes regulating bile acid homeostasis during liver regeneration. A. 
Quantitative RT-PCR analyses of hepatic mRNA abundance of BA synthesis genes Cyp7a1 and Cyp8b1, and immunoblotting of liver 
extracts using CYP7A1 and CYP8B1 antibodies. b. Quantitative RT-PCR analyses of ileal mRNA level of BA regulator Shp and Fgf15, 
and immunoblotting of ileal extracts using anti-SHP and FGF15 antibodies. c. Quantitative RT-PCR analyses of ileal mRNA level of BA 
transporter Oatp2, Abst, Ibabp, and Ostβ. D. RA had no effects on ileal mRNA level of BA transporter Abcg5, Abcg8, Ostα, and Abcb1. 
Means ± SD are graphed with * indicating p < 0.05.
Figure 4: the effect of rA on hepatic bile acid composition during liver regeneration. A. RA had no effect on hepatic total 
bile acids (TBA); b. RA shifted the percentages of indicated free bile acids in vehicle and RA-treated mice after PHx; c. the ratio of 
taurocholic acid (TCA) to cholic acid (CA), and D. the ratio of tauro-β-muricholic acid (T-β-MCA) to β-muricholic acid (β-MCA). Means 
± SD are graphed with * indicating p < 0.05.
Oncotarget1101www.impactjournals.com/oncotarget
rA regulates energy homeostasis by inducing 
FGF21 signaling
Fibroblast growth factor 21 (FGF21) is a master 
metabolic regulator that has a striking ability to reverse 
obesity, diabetes, and injury as well as prolong life span 
[34]. FGF21 is transiently induced during the early 
phase of liver regeneration [23]. RA treatment resulted 
in early induction of FGF21 mRNA and protein levels 
after PHx (Figure 5A). Serine/threonine kinase 11 
(LKB1), a downstream target of FGF21, also showed 
earlier induction in RA-primed mice after PHx. FGF21 
increases the phosphorylation of AMP-activated protein 
kinase (AMPK) through LKB1 [35]. Higher phospho-
AMPK level was found in RA-treated mice on day 0, 0.5, 
and 1.5, but RA did not alter total AMPK protein level 
(Figure 5A). AMPK has been shown to induce NAD+-
dependent deacetylase sirtuin 1 (SIRT1) activity (day 1 
and 2), resulting in modulation of downstream targets 
including peroxisome proliferator-activated receptor-γ 
coactivator 1α (Pgc1α), carnitine acyltransferase 1 (Cpt1), 
and sterol regulatory element-binding transcription factor 
1c (Srebp1c) [35]. Increased FGF21 was accompanied 
by elevated SIRT1, Pgc1α, and Cpt1 0-1 day after PHx 
(Figure 5B). In addition, PHx did not affect the total 
extracellular-signal-regulated kinase 1 and 2 (ERK1/2) 
level, but rather induced ERK1/2 phosphorylation, which 
was further increased by RA on day 0 and 0.5 day (Figure 
5B). 
Figure 5: the effect of rA on the expression of factors that regulate hepatic metabolism and cell proliferation during 
liver regeneration. A. Quantitative RT-PCR analyses of hepatic mRNA abundance of Fgf21, and immunoblotting of liver extracts using 
FGF21, LKB1, p-AMPK, and t-AMPK antibodies. b. Immunoblotting of liver extracts using SIRT1, p-ERK1/2, and t-ERK1/2 antibodies, 
and Quantitative RT-PCR analyses of hepatic mRNA abundance of Pgc1α, Cpt1, and Srebp1c. Means ± SD are graphed with * indicating 
p < 0.05.
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DIscUssION
Emerging evidence indicates that bidirectional 
communication exists between the gut microbiota and BAs 
through a “gut-liver axis” [1, 25]. The gut microbiome has 
increasingly been acknowledged as a novel contributor to 
host metabolism [25, 27]. Mounting evidence in mice and 
humans supports that the gut microbiota is linked with 
metabolic disorders such as diabetes and obesity [1, 27]. 
Liver resection changes lipid and BA metabolism during 
a period when increased energy production is needed to 
meet the metabolic demands of cell proliferation [36]. 
We demonstrated, for the first time, that RA altered the 
gut microbiota composition and BA profile, which was 
accompanied by an increase in energy metabolism, 
beneficial for liver regeneration. 
Alterations in gut microbiota composition have been 
implicated in metabolic disorders, and specific bacterial 
phylotypes or metabolic activities may be beneficial or 
detrimental to patients with obesity [1, 8]. Firmicutes and 
Bacteroidetes are the two most dominant bacterial phyla 
that affect the efficiency of host energy extraction and are 
linked with excess adiposity in both mice and humans 
[13, 37]. Obese mice have more Firmicutes and fewer 
Bacteroidetes compared to lean mice. The role of RA in 
regulating lipid homoestasis had been defined by genomic 
binding and transcriptome profiling [29]. Decreased lipid 
accumulation and the ratio of Firmicutes to Bacteroidetes 
presented in RA-primed mice are associated with 
accelerated liver regeneration, indicating beneficial lipid 
metabolism induced by RA during liver regeneration. 
Phyla Verrucomicrobia is occasionally observed, 
and is capable of pathogenic activity with growth 
inhibition toward the host [38, 39]. Lachnospiraceae 
and Ruminococcaceae are the most abundant Firmicute 
families in the intestines, accounting for roughly 50% and 
30% of phylotypes, respectively in healthy adults [40, 41]. 
Lachnospiraceae and Ruminococcaceae, associated with 
the production of butyrate necessary for colonic epithelial 
health, have been shown to be depleted in inflammatory 
bowel disease patients [42, 43]. The gut microbiota exerts 
a strong influence on energy homeostasis due to bacteria-
produced butyrate which serves as an energy source for 
colonocytes [44]. The increased Lachnospiraceae and 
Ruminococcaceae due to RA treatment may increase 
butyrate production, which may benefit liver regeneration. 
BAs are efficiently conserved under normal 
conditions by a process termed enterohepatic recirculation 
[33]. Conjugated and unconjugated BAs are reabsorbed 
by passive diffusion along the entire gut and by active 
transport in the terminal ileum. BA overload has been 
observed after liver resection, and Cyp7a1 and Cyp8b1 
inhibition indicate the necessity to down-regulate BA 
synthesis during liver regeneration [23, 24]. Cyp7a1 
expression can be regulated by a negative feedback loop 
involving intestinal BA signaling [22, 33]. RA-mediated 
induction of SHP and Fgf15 has been shown to mediate this 
suppression [30]. During liver regeneration, RA can boost 
this Fxr-mediated pathway to further inhibit hepatic BA 
synthesis. Asbt absorbs the majority of BAs available in 
the adjacent lumen of the ileum and is critical for intestinal 
BA reabsorption during enterohepatic recirculation [45]. 
Mutation or inhibition of Asbt causes BA malabsorption 
and interruption of the enterohepatic circulation of BAs 
resulting in chronic diarrhea, steatorrhea, and fat-soluble 
vitamin malabsorption [45, 46]. In the intestines, BAs are 
transported by Ibabp, after which they are secreted back 
into circulation by several transporters including Ostα/β. 
The up regulation of these genes found in regenerating 
livers can accelerate BA circulation, thereby protecting 
hepatocytes against high concentration of BAs. Together, 
the presented data illustrated that in response to liver 
resection, the enterohepatic recirculation adapted to the 
immediate BA overload by inhibiting hepatic BA synthesis 
and inducing intestinal BAs transporters, both of which 
were enhanced by RA.
It is possible that through gut microbiota-modulated 
BA composition, RA facilitated metabolism, which 
contributed to accelerated liver regeneration. Metabolism 
of BAs by gut microbes increases BA diversity, thus not 
only affecting BA and lipid homeostasis, but also other 
aspects of host health [8]. For example, BSH activity, 
produced in significant amounts by Lactobacillus and 
Bifidobacterium, could be a way for bacterial species 
to detoxify BAs [8]. In addition, the dehydroxylation 
of chenodeoxycholic acid (CDCA) forms LCA, which 
is toxic to hepatocytes and has been linked to colon 
carcinogenesis [28]. Conversely, epimerization of 
CDCA generates ursodeoxycholic acid (UDCA), which 
is chemoprotective and is used to treat cholesterol 
gallstone [47]. Furthermore, conjugated BAs reduce the 
hydrophobic/hydrophilic ratio and are more effective in 
lipid emulsification and micelle formation. The presented 
data revealed a shift towards hydrophilic and conjugated 
BAs in RA-treated mice. Together, RA treatment may 
exert beneficial BA metabolism by intestinal microbes for 
liver regeneration.
FGF21 is required for activation of hepatic lipid 
oxidation, triglyceride clearance, and ketogenesis during 
fasting [48]. Administration of FGF21 to rodents with 
diet-induced or genetic obesity and diabetes resulted in 
potent antihyperglycemic and triglyceride lowering effects 
[35]. Forced FGF21 expression in partial hepatectomized 
hPPARαPAC mice reduced hepatic steatosis, prevented 
focal necrosis, and restored liver mass [23]. LKB1 
and AMPK are required for FGF21-mediated energy 
regulation of mitochondrial oxidative function [35] via 
Pgc1α, Cpt1, and Srebp1c [49, 50]. Inhibition of AMPK 
activity attenuated FGF21-stimulated increase in Cpt1 and 
Pgc1α gene expression [35]. Both AMPK and SIRT1 act 
together with Pgc1α, the master regulator of mitochondrial 
biogenesis, to modulate energy homeostasis in response to 
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environmental and nutritional stimuli [35]. The sustained 
activation of ERK1/2, can also be regulated by FGF21 to 
induce stimulatory cell cycle regulators [51]. Transient 
accumulation of hepatocellular fat during the early stage 
of liver regeneration has been proposed to serve as an 
β-oxidation energy source for hepatocellular proliferation 
[52]. Consistently, infusion of octanoylcarnitine, an 
inhibitor of β-oxidation, decreased DNA synthesis and 
energy charge levels in regenerating livers [53]. Mice 
treated with RA seem to have increased efficiency in 
lipid transport and metabolism, which is suggested by 
a lack of lipid accumulation and accelerated hepatocyte 
proliferation. 
In summary, our data showed that RA-accelerated 
liver regeneration was accompanied by a decreased ratio 
of Firmicutes to Bacteroidetes, which is known to be 
associated with a lean phenotype. Consistently, RA-primed 
mice lacked the transient lipid accumulation normally 
found in regenerating mouse livers. In addition, RA altered 
BA signaling, enhanced enterohepatic recirculation of 
BAs, and increased the hydrophilic/hydrophobic ratio of 
BAs in the regenerating livers, potentially yielding higher 
solubility and lipid emulsification capability in RA-primed 
mice. RA-priming afforded more efficient lipid circulation 
and induction of the FGF21-LKB1-AMPK pathway, 
which boosted the energy metabolism necessary for liver 
regeneration. A better mechanistic understanding of the 
proliferative effects exerted by RA through modulating gut 
microbiota composition may allow for the development of 
therapeutics to promote liver regeneration in the clinical 
setting.
MAtErIALs AND MEtHODs
Animal
Male C57BL/6 mice (3-5 months old) were housed 
in steel microisolator cages at 22°C with a 12-hour light/
dark cycle. Food and water were provided ad libitum 
throughout study. RA (25 μg/gram of body weight, one 
time) (Sigma-Aldrich Corp., St. Louis, MO) or vehicle 
control (carboxymethyl cellulose) (Sigma-Aldrich Corp., 
St. Louis, MO) was administered to the mice by gavage. 
Forty-eight hours after treatment, 2/3 PHx was performed 
[31, 54, 55]. Mice were killed 0.5, 1, 1.5, and 2 days after 
surgery (n = 4) covering the time when hepatocytes are 
actively proliferating. Zero time point mice, which were 
killed immediately after PHx, served as controls (0 day). 
All animal experiments were conducted in accordance 
with the National Institutes of Health Guide for the Care 
and Use of Laboratory Animals under protocols approved 
by the Institutional Animal Care and Use Committee of 
the University of California, Davis.
sequencing and analysis of gut microbial 
communities in the cecal contents
Cecal DNA was extracted using the MoBio power 
soil kit (MoBio) according to the manufacturer’s protocol. 
Multiplexed DNA libraries were prepared according to a 
previously described protocol [56]. In brief, the V4 domain 
was amplified using primers 515F and 806R, a set of 
prokaryotic universal primers that was well-validated and 
used as the standard protocol for the Earth Microbiome 
Project (http://www.earthmicrobiome.org/), with a unique 
identifier sequence for each sample. Polymerase chain 
reaction (PCR) mixtures contained 1 Unit Kapa2G Robust 
Hot Start Polymerase (Kapa Biosystems), 1.5 mM MgCl2, 
10 pmol of each primer, and 2 ng of DNA. PCR included 
95°C for 2 minutes, followed by 30 cycles of 95°C for 15 
seconds, 55°C for 30 seconds, and 72°C for 45 seconds 
and a final extension of 72°C for 3 minutes. The amplicon 
libraries were sequenced using 2 × 250-bp paired-end 
protocol on an Illumina Miseq system. Sequencing reads 
were trimmed of their barcodes, demultiplexed and 
combined using custom Perl scripts and aligned to the 
Greengenes (release 13_5) database using Qiime with 
default parameters.
Quantification of bile acids
BAs were analyzed using a ProminenceTM UFLC 
system (Shimadzu, Kyoto) coupled to an API 4000 
QTRAPTM mass spectrometer (AB Sciex, CA) operated in 
negative ionization mode based on published methods [23, 
57, 58]. Chromatography was performed on a Kinetex C18 
column (50 mm X 2.1 mm, 2.6 μm) maintained at 40°C 
preceded by high pressure column prefilter. The mobile 
phase consisted of methanol gradient delivered at a flow 
rate of 0.4 ml/min.
real-time quantitative Pcr (qPcr)
Hepatic RNA isolated by TRIzol (Invitrogen, 
Carlsbad, CA) was reverse transcribed to generate cDNA 
followed by amplification using the ABI Prism 7900HT 
sequence detection system (Applied Biosystems, Foster 
City, CA). The hepatic mRNA levels were normalized to 
Gpadh mRNA levels. 
Western blot
Hepatic and ileal proteins (40 µg) were 
electrophoresed on SDS-polyacrylamide gels and 
transferred to polyvinylidene fluoride membranes. Anti-
SHP, FGF15, FGF21, CYP7A1, CYP8B1, LKB1, AMPK, 
and β-actin (Santa Cruz, CA) antibodies were used for 
detection the specific proteins.
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statistical analysis
Data are given as mean ± SD. Statistical analysis 
was performed using Student’s t test or one-way analysis 
of variance. Significance was defined by p < 0.05.
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